However interestingly, it seems that HER2-positive subtype was the only subgroup that had a prognostic association with IGF2 expression among the 4 molecular subgroups of breast cancer based on the TCGA database (including overall survival (OS), recurrence free survival (RFS) and distant metastasis-free survival (DMFS)). This evidence concerns the gene IGF2 and breast carcinoma.